...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Technology Management: The Journal of the Technology Management of Technology, Engineering Management, Technology Policy and Strategy >Pharmaceutical R&D in an era of managed healthcare: using integrative teams to produce enduring competitive advantage
【24h】

Pharmaceutical R&D in an era of managed healthcare: using integrative teams to produce enduring competitive advantage

机译：管理型医疗时代的药物研发：利用整合团队创造持久的竞争优势

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Medical technology organizations are faced with greater performance pressure in the new managed healthcare environment. In particular, pharmaceutical research and development (R&D) organizations are expected to create new and useful therapeutic treatments with greater resource constraints than ever previously experienced. We explore how pharmaceutical R&D organizations are changing the way they manage the research process in response to changing organizational and environmental constraints. This paper suggests an integrative team approach to the efficient and effective management of pharmaceutical R&D in a managed healthcare environment. We view integrative teams as an important means of increasing R&D productivity and producing competitive advantage. [References: 35]
机译：在新的托管医疗环境中，医疗技术组织面临更大的性能压力。特别是，制药研究与开发（R＆D）机构有望创造出比以往任何时候都具有更大资源限制的新型有用治疗方法。我们探讨了制药研发组织如何根据不断变化的组织和环境约束来改变他们管理研究过程的方式。本文提出了在可管理的医疗环境中有效地管理药物研发的综合团队方法。我们将集成团队视为提高研发生产率和产生竞争优势的重要手段。 [参考：35]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号